Jabil has acquired Pharmaceutics International (Pii), a CDMO, to enhance its pharmaceutical offerings for drug development customers. The addition of Pii's expertise and services strengthens Jabil's capabilities in clinical trials, commercial production, and drug manufacturing.
Read MoreDid you find this insightful?
Amazing
Bad
Just Okay